Cargando…
Chinese health biotech and the billion-patient market
Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.
Autores principales: | Frew, Sarah E, Sammut, Stephen M, Shore, Alysha F, Ramjist, Joshua K, Al-Bader, Sara, Rezaie, Rahim, Daar, Abdallah S, Singer, Peter A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/ https://www.ncbi.nlm.nih.gov/pubmed/18183014 http://dx.doi.org/10.1038/nbt0108-37 |
Ejemplares similares
-
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators
por: Rezaie, Rahim, et al.
Publicado: (2012) -
Biotech for Wildlife
Publicado: (1993) -
Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path
por: Al-Bader, Sara, et al.
Publicado: (2010) -
Pigments market to surpass EUR 18,8 billion by 2027
Publicado: (2020) -
Campus Biotech summary
por: MORIN, Jean-Henry, et al.
Publicado: (2015)